loadpatents
Patent applications and USPTO patent grants for Cansfield; Julie Elaine.The latest application filed is for "muscarinic receptor agonists".
Patent | Date |
---|---|
Pharmaceutical compounds Grant 11,352,342 - Brown , et al. June 7, 2 | 2022-06-07 |
Muscarinic agonists Grant 11,254,656 - Brown , et al. February 22, 2 | 2022-02-22 |
Muscarinic Receptor Agonists App 20220048928 - Congreve; Miles Stuart ;   et al. | 2022-02-17 |
Muscarinic M1 Receptor Agonists App 20210353637 - Congreve; Miles Stuart ;   et al. | 2021-11-18 |
Muscarinic receptor agonists Grant 11,034,704 - Congreve , et al. June 15, 2 | 2021-06-15 |
Muscarinic M1 receptor agonists Grant 10,973,832 - Congreve , et al. April 13, 2 | 2021-04-13 |
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor Grant 10,961,225 - Brown , et al. March 30, 2 | 2021-03-30 |
Pharmaceutical Compounds App 20210040067 - Brown; Giles Albert ;   et al. | 2021-02-11 |
Muscarinic Agonists App 20200354339 - Brown; Giles Albert ;   et al. | 2020-11-12 |
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor App 20200325118 - Brown; Giles Albert ;   et al. | 2020-10-15 |
Pharmaceutical compounds Grant 10,752,610 - Brown , et al. A | 2020-08-25 |
Muscarinic M1 Receptor Agonists App 20200253982 - Kind Code | 2020-08-13 |
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor Grant 10,689,368 - Brown , et al. | 2020-06-23 |
Muscarinic Receptor Agonists App 20200017530 - Congreve; Miles Stuart ;   et al. | 2020-01-16 |
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor App 20190337925 - Brown; Giles Albert ;   et al. | 2019-11-07 |
Muscarinic receptor agonists Grant 10,428,088 - Congreve , et al. October 1, 2 | 2019-10-01 |
Muscarinic M1 receptor agonists Grant 10,413,553 - Congreve , et al. Sept | 2019-09-17 |
Pharmaceutical Compounds App 20190276437 - Brown; Giles Albert ;   et al. | 2019-09-12 |
Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists Grant 10,385,039 - Brown , et al. A | 2019-08-20 |
Pharmaceutical compounds Grant 10,329,278 - Brown , et al. | 2019-06-25 |
Bicyclic Aza Compounds As Muscarnic M1 Receptor And/or M4 Receptor Antagonists App 20190112294 - Brown; Giles Albert ;   et al. | 2019-04-18 |
Bicyclic aza compounds as muscarinic M1 receptor antagonists Grant 10,259,802 - Brown , et al. | 2019-04-16 |
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists Grant 10,196,380 - Brown , et al. Fe | 2019-02-05 |
Spirocyclic compounds as agonists of the muscarinic M.sub.1 receptor and/or M.sub.4 receptor Grant 10,167,284 - Congreve , et al. J | 2019-01-01 |
Pharmaceutical Compounds App 20180362507 - Brown; Giles Albert ;   et al. | 2018-12-20 |
Muscarinic Receptor Agonists App 20180327426 - Congreve; Miles Stuart ;   et al. | 2018-11-15 |
Bicyclic Aza Compounds As Muscarinic M1 Receptor Antagonists App 20180258085 - Brown; Giles Albert ;   et al. | 2018-09-13 |
Muscarinic receptor agonists Grant 10,030,035 - Congreve , et al. July 24, 2 | 2018-07-24 |
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor Agonists App 20180179184 - Brown; Giles Albert ;   et al. | 2018-06-28 |
Muscarinic M1 Receptor Agonists App 20180153900 - Congreve; Miles Stuart ;   et al. | 2018-06-07 |
Bicyclic AZA compounds as muscarinic M1 receptor antagonists Grant 9,975,890 - Brown , et al. May 22, 2 | 2018-05-22 |
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists Grant 9,926,297 - Brown , et al. March 27, 2 | 2018-03-27 |
Spirocyclic Compounds As Agonists Of The Muscarinic M1 Receptor And/or M4 Receptor App 20180072727 - Congreve; Miles Stuart ;   et al. | 2018-03-15 |
Muscarinic M1 receptor agonists Grant 9,907,805 - Congreve , et al. March 6, 2 | 2018-03-06 |
Bicyclic Aza Compounds As Muscarinic M1 Receptor Antagonists App 20170247369 - Brown; Giles Albert ;   et al. | 2017-08-31 |
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor Agonists App 20170240530 - Brown; Giles Albert ;   et al. | 2017-08-24 |
Muscarinic M1 Receptor Agonists App 20170157139 - Congreve; Miles Stuart ;   et al. | 2017-06-08 |
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists Grant 9,670,183 - Brown , et al. June 6, 2 | 2017-06-06 |
Bicyclic aza compounds as muscarinic M1 receptor agonists Grant 9,669,013 - Brown , et al. June 6, 2 | 2017-06-06 |
Muscarinic Receptor Agonists App 20170096437 - Congreve; Miles Stuart ;   et al. | 2017-04-06 |
Muscarinic M1 receptor agonists Grant 9,573,929 - Congreve , et al. February 21, 2 | 2017-02-21 |
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor Agonists App 20170015650 - Brown; Giles Albert ;   et al. | 2017-01-19 |
Bicyclic Aza Compounds As Muscarinic M1 Receptor Agonists App 20160128996 - Brown; Giles Albert ;   et al. | 2016-05-12 |
Muscarinic M1 Receptor Agonists App 20160068508 - Congreve; Miles Stuart ;   et al. | 2016-03-10 |
Bicyclic AZA compounds as muscarinic M1 receptor agonists Grant 9,266,857 - Brown , et al. February 23, 2 | 2016-02-23 |
Bicyclic Aza Compounds As Muscarinic M1 Receptor Agonists App 20150232443 - Brown; Giles Albert ;   et al. | 2015-08-20 |
Calcium Ion Channel Modulators & Uses Thereof App 20110166136 - Khan; Nawaz Mohammed ;   et al. | 2011-07-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.